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Greater understanding of normal hip physical function may guide clinicians in providing targeted 1 
rehabilitation programs 2 
 3 
ABSTRACT: 4 
 5 
Objective: This study investigated tests of hip muscle strength and functional performance.  The 6 
specific objectives were to: i) establish intra- and inter-rater reliability; ii) compare differences 7 
between dominant and non-dominant limbs; iii) compare agonist and antagonist muscle strength 8 
ratios; iv) compare differences between genders; and v) examine relationships between hip muscle 9 
strength, baseline measures and functional performance 10 
 11 
Design: Reliability study and cross-sectional analysis of hip strength and functional performance. 12 
 13 
Methods: In healthy adults aged 18-50 years, normalized hip muscle peak torque and functional 14 
performance were evaluated to: i) establish intra-rater and inter-rater reliability; ii) analyse 15 
differences between limbs, between antagonistic muscle groups and genders; and iii) associations 16 
between strength and functional performance.   17 
 18 
Results: 19 
Excellent reliability (intra-rater ICC=0.77–0.96; inter-rater ICC=0.82–0.95) was observed. No 20 
difference existed between dominant and non-dominant limbs. Differences in strength existed 21 
between antagonistic pairs of muscles: hip abduction was greater than adduction (p<0.001) and hip 22 
ER was greater than IR (p<0.001). Men had greater ER strength (p=0.006) and hop for distance 23 
(p<0.001) than women. Strong associations were observed between measures of hip muscle 24 
strength (except hip flexion) and age, height, and functional performance. 25 
 26 
2 
 
Conclusions: 1 
Deficits in hip muscle strength or functional performance may influence hip pain. In order to provide 2 
targeted rehabilitation programs to address patient-specific impairments, and determine when 3 
individuals are ready to return to physical activity, clinicians are increasingly utilising tests of hip 4 
strength and functional performance. This study provides a battery of reliable, clinically-applicable 5 
tests which can be used for these purposes.  6 
 7 
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 1 
 Introduction: 2 
Reduced hip strength is a common feature of conditions involving the hip joint, such as hip 3 
osteoarthritis (OA)1 2 and femoroacetabular impingement (FAI)3 4. In addition, reduced hip muscle 4 
strength has been shown to be associated with increased prevalence of lower limb injury in 5 
runners5; and with subsequent acute groin injuries in professional ice hockey players6. As a result, 6 
many prevention or intervention programs are targeted towards improving hip strength and physical 7 
function7 8. In the clinical setting, the ability to measure and interpret hip strength and physical 8 
function is therefore necessary to guide and monitor appropriate treatments.  9 
 10 
Muscle strength and functional performance of the hip can be difficult to assess reliably. Hand held 11 
dynamometry (HHD) is one option for measuring peak isometric hip muscle strength9-11. 12 
Measurement of hip muscle strength is increasingly being used as a screening tool to potentially 13 
assist in the identification of individuals at risk of hip problems 4. Muscle strength assessment has 14 
been shown to be reliable with a single rater in active, healthy adults10, in older adults with hip 15 
osteoarthritis12 and in footballers13. However, not all studies report the standard error of 16 
measurement (SEM), and the inter-rater reliability of using HHD for measuring hip muscle strength 17 
has not been evaluated to date. Finally, tests of functional performance of the lower limb such as 18 
the single leg hop for distance14 and side bridge test15 may also be valuable to guide rehabilitation, 19 
but little is known about the reliability of these tests. Therefore, the reliability of hip strength and 20 
commonly used tests of hip functional performance needs further evaluation. 21 
 22 
Hip muscle strength is also used to monitor progress and guide treatment following injury11 16. 23 
Knowledge of the balance of hip muscle strength between dominant and non-dominant limbs and 24 
between agonist and antagonist muscle groups may assist clinical decision making. Studies have 25 
investigated dominant versus non-dominant and agonist versus antagonist strength differences for 26 
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the hip abductors and adductors11 16 17. However these studies were undertaken in elite athletes. To 1 
our knowledge no studies have examined these factors in non-elite physically active adults.  In 2 
addition, no studies have examined these relationships in other key muscle groups surrounding the 3 
hip. As a consequence, there is a need to develop a more complete understanding of both dominant 4 
versus non-dominant and agonist versus antagonist muscle strength profiles in all hip muscle groups 5 
in non-elite physically active adults. 6 
 7 
Gender may be an important factor in hip pathologies. The prevalence of symptomatic and 8 
asymptomatic cam-type FAI is greater in males than in females18, and pincer type FAI is greater in 9 
females than males 19, while the prevalence of hip OA is reported to be higher in females20. Such 10 
gender biases may be related, in part, to differences in hip muscle strength. Two studies have 11 
demonstrated gender-related differences in strength do exist for a cohort of healthy controls21 22, 12 
however they examined hip abductor and external rotator muscle strength only. Another study 13 
demonstrated males with hip OA have reduced strength of the hip abductors, adductors and flexors 14 
compared to controls2. Enhanced knowledge of gender-related differences in hip muscle strength 15 
and functional performance may assist in providing appropriate gender-specific rehabilitation 16 
programs. 17 
 18 
The aims of this study were, in a cohort of healthy adults, to: (i) establish the intra- and inter-rater 19 
reliability of hip strength HHD assessments and functional performance measures; (ii) compare the 20 
hip strength and functional performance of the dominant versus non-dominant lower-limb; (iii) 21 
calculate the ratio between the strength of agonist and antagonist hip muscle groups; (iv) compare 22 
hip muscle strength and functional performance between genders; and (v) test whether any 23 
relationship exists between measures of hip muscle strength and participant baseline characteristics 24 
as well as functional performance. 25 
 26 
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METHODS: 1 
 2 
Participants aged between 18 and 50 years were recruited from the community via advertisements 3 
in local print media and posters. A cohort of 15 people were recruited for the reliability study, (age 4 
28 ±4 years; 1.73 ±0.06m; 68 ±13kg; BMI 22.4 ±3.3)kg/m2). A separate cohort of 57 people were 5 
recruited for Hip muscle strength and functional performance testing (age 34 ±9 years; 1.71 ±0.09m; 6 
69 ±12kg; BMI 23.5 ±3.)kg/m2 - The complete baseline characteristics are contained in 7 
Supplementary Material Table 1. Participants were excluded if they currently suffered low back pain 8 
or other lower limb injury, could not walk without assistance, had a history of hip pain in the 9 
previous 6 months, had undergone hip surgery, or had an inability to read or speak English. All 10 
participants provided written informed consent and the study was approved by the University of 11 
Melbourne Human Research Ethics Committee (HREC number 1033739 and 1033063).  12 
 13 
Intra-rater reliability was evaluated by single tester performing two assessment sessions separated 14 
by one week. Inter-rater reliability was evaluated by two testers performing a single assessment 15 
session on the same day. Both examiners were female sports physiotherapists with at least 10 years 16 
of clinical experience. Measurements of hip strength and functional performance were collected by 17 
the same tester (JLK) using a standardised order of testing.   18 
 19 
All strength tests were performed with a Commander Power track II (J-Tech medical) HHD. The 20 
tester matched the force generated by the participant performing an isometric muscle contraction 21 
(i.e. “make” test)16. The best of three tests was recorded. Visible marks were placed on the legs of 22 
participants to guide placement of the force transducer for the HHD strength assessments and to 23 
allow moment arm lengths to be calculated. Moment arm length was measured from the joint axis 24 
of rotation to the point of application of the force transducer for each test. For each test, torque was 25 
calculated by multiplying the force (measured in Newtons (N)) by the length of the moment arm 26 
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(measured in metres (m)), and then data were normalized for body weight (measured in kilograms 1 
(kg)) (i.e. Nm/kg). All tests were conducted on both legs. Strength measures assessed included hip 2 
flexion, extension, external rotation in both neutral and 90 degrees of hip flexion, internal rotation in 3 
both neutral and 90 degrees of hip flexion, abduction and adduction. Strength testing set up 4 
procedures are contained in Supplementary Material Figures 1a-h. 5 
 6 
Functional performance measures included the Side Bridge test15 and the single leg hop for distance 7 
(HFD) test14.  Testing procedures for Side Bridge, which was modified from its original description, 8 
are contained in Supplementary Material Figure 2, and HFD in Supplementary Material Figure 3. 9 
 10 
Data analysis was performed using PASW for Graduate Students, SPSS for Windows, Version 18 11 
(SPSS Inc., Chicago IL USA). The sample size for Part one was determined based on procedures 12 
described by Walter et al23, whereby 15 participants was deemed to be acceptable for two raters, 13 
with α=0.05 and β=0.20 (power = 0.8). 14 
 15 
To determine reliability, the intra-class correlation coefficient (ICC) and standard error of 16 
measurement (SEM) for each outcome measure were calculated. The SEM was calculated using the 17 
formula SEM = SD x √1-ICC, where the SD is the SD of all of the scores for a particular test. Reliability 18 
was interpreted based on established criteria, where ‘good’ reliability was deemed to be ICC ≥ 75%; 19 
‘moderate’ reliability was within the range of ICC ≤ 75% and ≥ 40%; and ‘poor’ reliability was ICC ≤ 20 
40%24. The SEM was also expressed as a percentage, which was calculated by dividing the SEM with 21 
the average of the test and retest values.  22 
 23 
Paired t-tests were performed to determine the mean difference between dominant versus non-24 
dominant limbs and agonist versus antagonist muscle groups for all outcome measures. 25 
Independent t-tests were used to determine the mean difference between males versus females. 26 
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The dominant limb was deemed to be that used to kick a ball, as utilized previously by Crossley et al 1 
25. Bivariate correlation (Pearson’s correlation coefficient (r)) was used to determine the association 2 
between measures of hip strength and measures of functional performance (for the dominant limb 3 
only). The critical value of r was determined at 0.325, greater than which the null hypothesis can be 4 
rejected 26. The significance criteria for all tests was determined a priori as ρ=0.01 5 
 6 
Results 7 
The reliability of hip strength and functional measures are summarised in Supplementary Material 8 
Table 2. ICC values of greater than 0.77 for both intra-rater and inter-rater reliability were observed 9 
for all measures. All but two measures demonstrated ICC values greater than 0.85. The SEM ranged 10 
from 2.5% (HFD inter-rater reliability) to 14.4% (extension and adduction strength inter-rater 11 
reliability). 12 
 13 
No significant between-limb differences were found in strength for any muscle groups (Figure 1), or 14 
functional performance measures (HFD mean difference (99% CI) 0 metres (-0.036 to 0.022, 15 
p=0.505); SB mean difference (99% CI) -5 seconds (-11.6 to 2.2), p=0.076). The mean difference [99% 16 
CI] in abduction to adduction strength (0.19 [0.10 to 0.28]; p<0.001) and ER to IR strength tested at a 17 
neutral hip position (0.20 [0.15 to 0.24]; p<0.001) were significantly different (Figure 1). The 18 
extension and flexion strength (0.03 [-0.08 to 0.14]; p=0.491) and ER to IR strength at 90° of hip 19 
flexion (0.03 [0.00 to 0.07]; p=0.024) were not significantly different. These findings are reflected in 20 
the ratios between agonist and antagonists; which were significantly greater than 1.0 for abduction 21 
to adduction (1.13) and ER to IR at neutral hip flexion (1.32), but not for flexion to extension (1.02) 22 
or ER to IR at 90° (1.04). 23 
 24 
Gender-related differences in hip strength and functional performance for the dominant limb only, 25 
between males and females, are outlined in Table 1. Males exhibit significantly greater strength 26 
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(peak torque normalised for body weight) than females only in ER (p=0.006), tested in a neutral hip 1 
position. Large differences were seen between males and females for functional performance in the 2 
single leg HFD (p<0.001) only.  3 
 4 
Correlations between hip strength measures and participant characteristics as well as functional 5 
performance measures are outlined in Table 2. Age and height correlated significantly with all hip 6 
strength measures, with the exception of hip flexion strength. The HFD test and the side bridge test 7 
also correlated significantly with all measures of hip strength, with the exception of hip flexion.  8 
 9 
Discussion 10 
 11 
In a cohort of healthy individuals, aged 18-50 years, we identified that all measures of hip muscle 12 
strength and functional performance displayed good (ICC > 0.75) intra- and inter-rater reliability. 13 
While dominant and non-dominant limbs did not differ in hip strength or functional performance, 14 
agonist to antagonist ratios revealed abduction strength was greater than adduction strength and ER 15 
strength was higher than IR strength at neutral hip flexion. Men exhibited higher ER strength as well 16 
as greater HFD performance than women. Finally, strong associations were observed between all hip 17 
strength measures (except hip flexion) and the HFD and side bridge tests. This study offers new 18 
knowledge which may be useful for clinicians to facilitate the development of targeted rehabilitation 19 
programs and determine readiness for return to activity for people with physical impairments of the 20 
hip joint.  21 
 22 
We demonstrated that commonly used clinical tests of physical function of the hip can be reliably 23 
performed between sessions and between testers.  In addition, the SEM calculated in the present 24 
study provides clinicians with a guide to the measurement error for these tests, enabling them to 25 
determine whether a true change has been seen in the physical outcome following an intervention. 26 
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Whilst the SEM has been established previously for intra-rater reliability10, our study is the first to 1 
our knowledge to also establish this value for inter-rater reliability. The inter-rater SEM is of 2 
importance when testing is undertaken by different clinicians. Our results are similar to Thorborg et 3 
al 10 who tested the reliability of HHD, despite differences in test set up, and activity levels of 4 
cohorts. Our results indicate that changes of up to 14% for most measures would be required for 5 
observed differences to be greater than error. With an increasing need to justify the effects of 6 
treatments to third parties funding physical rehabilitation programs, it is essential for clinicians to 7 
have a battery of reliable measures of physical function capable of being used to demonstrate a 8 
meaningful change.  9 
 10 
When assessing hip muscle strength and functional performance in those with or at risk of hip 11 
pathology, knowledge of the relative strength between dominant and non-dominant limbs or 12 
antagonists and agonist muscle groups can assist in the interpretation of test results. We observed 13 
no differences between the dominant versus non-dominant lower-limb for any measure of isometric 14 
hip muscle strength or functional performance. Our findings are similar to those by Thorborg et al.16, 15 
who examined isometric adductor and abductor strength in elite soccer players. This consistency 16 
was true despite differences in the activity levels of the cohort in our study and the cohort studied 17 
by Thorborg et al. Our results, combined with the findings of Thorborg et al., indicate that the use of 18 
the unaffected limb as a comparator when examining patients with unilateral lower-limb injury 19 
would be considered reasonable, in both athletic populations as demonstrated by Thorborg et al.16, 20 
and non-elite physically active adults as the current study demonstrates. 21 
 22 
Knowledge of the agonist to antagonist hip strength ratios in healthy individuals may provide 23 
comparator baseline measures for the clinician. Our observed ratio of 1.13 for the abductor to 24 
adductor strength indicates that in our cohort the abductors were stronger than the adductors 25 
(p<0.001).  Despite differences in the demographic variables and activity levels, this result is 26 
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consistent with the findings of Tyler et al.27, who found that hip adductor strength was 95% of hip 1 
abductor strength in painfree ice hockey players, and Thorborg et al.16, who reported a ratio of 1.05 2 
for abductor strength compared to adductor strength in soccer players without pain. Both previous 3 
studies observed lower abductor to adductor strength ratios athletes with groin pain 27 16, indicating 4 
that targeted rehabilitation may be required until the abductors are stronger than the adductors in 5 
this patient population. In addition to establishing the abductor to adductor strength ratios in non-6 
elite physically active adults, we also observed that the hip ER relative to IR strength ratio was 1.32, 7 
which has not been previously documented. Thus, rehabilitation and preventative programs should 8 
aim to restore these strength ratios. This information may be important when determining whether 9 
individuals with hip pathology or who have undergone hip surgery have recovered, or are ready to 10 
return to physical activity 16 27. In addition, these ratios may be helpful when comparing strength test 11 
results between therapists of differing stature, as these ratios should remain independent of tester 12 
strength.  13 
 14 
We expected men to have greater hip muscle strength than women28, even after accounting for size 15 
variation between genders by normalising torque measures for body weight. Our study confirmed 16 
that ER strength measures were higher in men, which was similar to the findings of a previous 17 
study21. However, the current study did not demonstrate significant differences between genders for 18 
hip abduction, adduction, flexion, extension or internal rotation strength. Our results differ from 19 
those of Leetun et al.21 and Jacobs et al.22 in that we did not find a difference between gender in hip 20 
abduction strength. However, Leetun et al. 21 tested trained athletes with a mean age of 19 years, 21 
which differs vastly from our population.  In addition these studies used different testing protocols 22 
and strength testing devices when measuring hip abduction strength. This knowledge is of 23 
importance, as performance on hip ER and IR strength by patients with hip pathology can be 24 
expected to be different for each gender. The incidence and type of hip pathology varies between 25 
males and females20, and a greater understanding of differences in physical performance between 26 
11 
 
genders may assist clinicians in the provision of individualised rehabilitation programs. In addition, it 1 
is possible that the differences seen in the incidence of hip pathology between males and females 2 
may be associated with the normal variations in strength and physical function reported in the 3 
present study.  4 
 5 
When examining the relationship between hip strength, participant characteristics and functional 6 
performance, the HFD correlated strongest with ER strength in 0˚ of hip flexion (r=0.624), whereas 7 
the side bridge test correlated strongest with ER (r=0.463) and IR (r=0.496) strength. In conditions 8 
where reduced strength of the hip ER is common (for example: patello-femoral joint pain29), the HFD 9 
and side bridge tests may be employed by clinicians as a gross surrogate indicator of hip ER strength 10 
in the absence of HHD assessment.  11 
 12 
The present study has some limitations. Due to the large age range of participants in this study, the 13 
results can be generalised to a range of people, but are not specific to an age group that may suffer a 14 
particular problem, for example athletic groin pain. In addition, as the two testers were female 15 
therapists of similar stature, the inter-rater reliability results may not be generalised to testers of 16 
different gender or body sizes. Further studies are needed to assess hip strength and functional 17 
performance in specific athletic populations, as the unique demands of elite sport will invariably 18 
mean that the results of strength and functional performance in uninjured athletes will be different 19 
from the results of the present study. 20 
 21 
Conclusion 22 
 23 
This study is important as it provides clinicians with a number of reliable, clinically-applicable tests to 24 
examine hip strength and functional performance. This knowledge is useful for clinicians as it may 25 
facilitate the development of targeted rehabilitation programs for people with physical impairments 26 
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of the hip. In addition, gender-related differences were found, which may assist future research in 1 
establishing causative factors for differences seen in incidence and types of hip pathology between 2 
males and females. Finally, it provides values that can be used as a reference for assessment and re-3 
assessment purposes, which may ultimately enable clinicians to provide targeted rehabilitation 4 
programs for their patients, and to set realistic objective goals in physical function. 5 
 6 
Practical Implications 7 
 Reliable and meaningful measures of hip physical function are essential for clinical practice, 8 
as they may guide optimal management and prevention of hip-related problems 9 
 This study comprehensively examined both hip muscle strength and functional performance 10 
in healthy adults 11 
 It provides values for reliable, clinical tests that can be used by clinicians as a reference for 12 
assessment and re-assessment purposes 13 
 The results may ultimately guide clinicians in providing targeted rehabilitation programs for 14 
their patients 15 
 16 
Acknowledgements: 17 
We gratefully acknowledge the assistance of                      in conducting reliability testing. 18 
                          is the recipient of an                              Grant. 19 
 20 
References: 21 
1. Arokoski MH, Haara M, Helminen HJ, Arokoski JP. Physical function in men with and without hip 22 
osteoarthritis. Archives of Physical Medicine & Rehabilitation 2004;85(4):574-81. 23 
2. Arokoski MHea. Hip muscle strength and cross sectional area in men with and without hip 24 
osteoarthritis. J Rheumatol 2002;29(10):2185-95. 25 
3. Nussbaumer S, et al. Validity and test-retest reliability of manual goniometers for measuring 26 
passive hip range of motion in femoroacetabular impingement patients. BMC 27 
Musculoskeletal Disorders 2010;11:194-204. 28 
13 
 
4. Casartelli NC, et al.,. Hip muscle weakness in patients with symptomatic femoroacetabular 1 
impingement. Osteoarthritis And Cartilage / OARS, Osteoarthritis Research Society 2 
2011;19(7):816-21. 3 
5. Niemuth PE, Johnson RJ, Myers MJ, Thieman TJ. Hip Muscle Weakness and Overuse Injuries in 4 
Recreational Runners. Clinical Journal of Sport Medicine 2005;15(1):14-21. 5 
6. Tyler TF, Nicholas SJ, Campbell RJ, McHugh MP. The Association of Hip Strength and Flexibility 6 
With the Incidence of Adductor Muscle Strains in Professional Ice Hockey Players. 7 
American Journal of Sports Medicine 2001;29:124-28. 8 
7. Enseki KR, Martin R, Kelly BT. Rehabilitation After Arthroscopic Decompression for 9 
Femoroacetabular Impingement. Clinics in Sports Medicine 2010;29(2):247-55. 10 
8. Philippon MJ, Christensen JC, Wahoff MS. Rehabilitation after arthroscopic repair of intra-11 
articular disorders of the hip in a professional football athlete. Journal of Sport 12 
Rehabilitation 2009;18(1):118-34. 13 
9. Hanna CM, Fulcher ML, Elley CR, Moyes SA. Normative values of hip strength in adult male 14 
association football players assessed by handheld dynamometry. Journal of Science and 15 
Medicine in Sport 2010;13(3):299-303. 16 
10. Thorborg K, Peterson J, Magnusson SP, Holmich P. Clinical assessment of hip strength using a 17 
hand held dynamometer is reliable. Scand J Med Sci Sports 2010;20:493-501. 18 
11. Thorborg K, Couppé C, Petersen J, Magnusson SP, Hölmich P. Eccentric hip adduction and 19 
abduction strength in elite soccer players and matched controls: A cross-sectional study. 20 
British Journal of Sports Medicine 2010. 21 
12. Pua YH, Wrigley TW, Cowan SM, Bennell KL. Intrarater Test-Retest Reliability of Hip Range of 22 
Motion and Hip Muscle Strength Measurements in Persons With Hip Osteoarthritis. 23 
Archives of Physical Medicine and Rehabilitation 2008;89(6):1146-54. 24 
13. Fulcher ML, Hanna CM, Raina Elley C. Reliability of handheld dynamometry in assessment of 25 
hip strength in adult male football players. Journal of Science and Medicine in Sport 26 
2010;13(1):80-84. 27 
14. Crossley KM, Thancanamootoo K, Metcalf BR, Cook JL, Purdam CR, Warden SJ. Clinical features 28 
of patellar tendinopathy and their implications for rehabilitation. Journal of Orthopaedic 29 
Research 2007;25(9):1164-75. 30 
15. McGill SM, Childs A, Liebenson C. Endurance times for low back stabilization exercises: Clinical 31 
targets for testing and training from a normal database. Archives of Physical Medicine and 32 
Rehabilitation 1999;80(8):941-44. 33 
16. Thorborg K, Serner A, Petersen J, Madsen TM, Magnusson P, Hölmich P. Hip Adduction and 34 
Abduction Strength Profiles in Elite Soccer Players: Implications for Clinical Evaluation of 35 
Hip Adductor Muscle Recovery After Injury. The American Journal of Sports Medicine 2010. 36 
17. Jacobs CA, Uhl TL, Seeley M, Sterling W, Goodrich L. Strength and Fatigability of the Dominant 37 
and Nondominant Hip Abductors. Journal Athletic Training 2005;43(3):203-06. 38 
18. Clohisy JC, Dobson MA, Robison JF, Warth LC, Zheng J, Liu SS, et al. Radiographic Structural 39 
Abnormalities Associated with Premature, Natural Hip-Joint Failure. JOURNAL OF BONE 40 
AND JOINT SURGERY -AMERICAN VOLUME- 2011;93:3-9. 41 
19. Beck M, Kalhor M, Leunig M, Ganz R. Hip morphology influences the pattern of damage to the 42 
acetabular cartilage. Femoroacetabular impingement as a cause of early osteoarthritis of 43 
the hip. Journal of Bone and Joint Surgery - Series B 2005;87(7):1012-18. 44 
20. Lievense AM, Bierma-Zeinstra S, Verhagen A, Verhaar JAN, Koes B. Prognostic Factors of 45 
Progress of Hip Osteoarthritis: A Systematic Review. Arthritis & Rheumatism 46 
2002;47(5):556-62. 47 
21. Leetun DT, Ireland ML, Willson JD, Ballantyne BT, Davis IM. Core Stability Measures as Risk 48 
Factors for Lower Extremity Injury in Athletes. Medicine & Science in Sports & Exercise 49 
2004;36(6):926-34. 50 
14 
 
22. Jacobs CA, Uhl TL, Mattacola C, Shapiro R, Rayens WS. Hip abductor function and lower 1 
extremity landing kinematics: Sex differences. J Ath Train 2007;42(1):76-83. 2 
23. Walter SD, M. Eliasziw, A. Donner. Sample size and Optimal design for Reliability studies. 3 
Statistics in Medicine 1998;17:101-10. 4 
24. Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychological 5 
Bulletin 1979;86(2):420-28. 6 
25. Crossley KM, Zhang W-J, Schache AG, Bryant A, Cowan SM. Performance on the Single-Leg 7 
Squat Task Indicates Hip Abductor Muscle Function. The American Journal of Sports 8 
Medicine 2011;39(4):866-73. 9 
26. Portney L, Watkins M. Foundations of Clinical Research - Applications to Clinical Practice. 3rd 10 
ed. Upper Saddle River, New Jersey: Pearson Education, 2009. 11 
27. Tyler TF, Nicholas SJ, Campbell RJ, McHugh MP. The association of hip strength and flexibility 12 
with the incidence of adductor muscle strains in professional ice hockey players. American 13 
Journal of Sports Medicine 2001;29(2):124-28. 14 
28. Danneskiold-Samsøe B, Bartels EM, Bülow PM, Lund H, Stockmarr A, Holm CC, et al. Isokinetic 15 
and isometric muscle strength in a healthy population with special reference to age and 16 
gender. Acta Physiologica 2009;197:1-68. 17 
29. Powers C. The Influence of Abnormal Hip Mechanics on Knee Injury: A Biomechanical 18 
Perspective. Journal of Orthopaedic & Sports Physical Therapy 2010;40(2):42-51. 19 
 20 
 21 
22 
15 
 
Tables 1 
Table 1: Between-group differences in strength and functional performance between genders 2 
TEST MALES* FEMALES* MEAN DIFFERENCE (99% CI) p-VALUE** %DIFFERENCE 
Extension
ǂ
 1.62(0.46) 1.49(0.44) 0.13 (-0.19 to 0.44) 0.305 8% 
Flexionǂ 1.50(0.47) 1.39(0.50) 0.11 (-0.21 to 0.43) 0.358 7% 
ER (90˚flex)ǂ 0.86(0.24) 0.71(0.21) 0.15 (-0.04 to 0.27) 0.057 17% 
IR (90˚ flex)ǂ 0.79(0.26) 0.69(0.21) 0.10 (-0.07 to 0.27) 0.119 13% 
ER (0  ˚flex)ǂ 0.94(0.32) 0.74(0.20) 0.20 (0.01 to 0.39) 0.006**                 21% 
IR (0˚ flex)ǂ 0.68(0.22) 0.56(0.15) 0.12 (-0.02 to 0.25) 0.024 18% 
ABDǂ 1.84(0.44) 1.65(0.35) 0.19 (-0.09 to 0.47) 0.077 10% 
ADDǂ  1.68(0.48) 1.46(0.36) 0.22 (-0.08 to 0.51) 0.055 13% 
SB (seconds) 101(38) 77(43) 24 (-8 to 56) 0.053 24% 
HFD (cm) 153(26) 111(31) 42 (20 to 63) <0.001** 27% 
*= mean (SD); ** statistically significant difference (p<0.01);
 ǂ 
= peak torque normalized for body weight (Nm/kg); EXT = extension; FLEX – 3 
flexion; ER = external rotation; IR = internal rotation; ABD = abduction; ADD = adduction; SB = side bridge; HFD = single leg  hop for distance 4 
5 
16 
 
Table 2: Associations between strength measures, participant characteristics and physical function 1 
(dominant limb)  2 
Strength measureǂ Age (r) Height (r) HFD (r) SB (r) 
Extension -0.338
*€ 
0.377
*€ 
0.442
*€ 
0.321
* 
Flexion -0.197 0.272 0.301 0.231 
ER@90 -0.392
*€ 
0.340
*€ 
0.436
*€ 
0.347
*€ 
IR@90 -0.331
*€ 
0.383
*€ 
0.386
*€ 
0.404
*€ 
ER@0 -0.331
*€ 
0.490
*€ 
0.624
*€ 
0.463
*€ 
IR@0 -0.360*€ 0.440*€ 0.565*€ 0.496*€ 
Abduction -0.437
*€ 
0.403
*€ 
0.404
*€ 
0.377
*€ 
Adduction -0.398
*€ 
0.382
*€ 
0.440
*€ 
0.397
*€ 
All associations calculated using the Pearson’s correlation coefficient (r)  3 
*=p<0.01; €=r greater than critical value of 0.325 to reject the null hypothesis 4 
ǂ
=peak torque(Nm) adjusted for body mass 5 
ER@90= external rotation measured at 90 degrees hip flexion; IR@90 = internal rotation measured at 90 degrees hip flexion; ER@0 = 6 
external rotation measured at zero degrees hip flexion; IR@0 = internal rotation measured at zero degrees hip flexion. 7 
BMI=body mass index (kg/m
2
); HFD = hop for distance; SB = side bridge test 8 
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Figure Legends 1 
Figure 1a 2 
Strength values dominant vs. non-dominant leg 3 
ER@90= external rotation measured at 90 degrees hip flexion; IR@90 = internal rotation measured 4 
at 90 degrees hip flexion; ER@0 = external rotation measured at zero degrees hip flexion; IR@0 = 5 
internal rotation measured at zero degrees hip flexion. 6 
Figure 1b 7 
Strength values agonist vs. antagonist muscle group ratio 8 
Ext:Flex = hip extension to hip flexion strength ratio; Abd:Add = hip abduction to hip adduction 9 
strength ratio; ER:IR@0 = hip external rotation to hip internal rotation strength ratio measured in 0˚ 10 
hip flexion; ER:IR@90 = hip external rotation to hip internal rotation strength measured at 90˚ hip 11 
flexion.  12 
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